FDA.reportPublic FDA data

Cosopt (dorzolamide 20 MG / timolol 5 MG) per ML Ophthalmic Solution

RxCUI
1923433
RxNorm name
Cosopt (dorzolamide 20 MG / timolol 5 MG) per ML Ophthalmic Solution
Display name
Cosopt (dorzolamide 20 MG / timolol 5 MG) per ML Ophthalmic Solution
Full name
Cosopt (dorzolamide 20 MG / timolol 5 MG) per ML Ophthalmic Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
COSOPTDORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEThea Pharma Inc.23bdf1c1-3134-4ad1-8e7c-bc655156bdc62024-04-17Warnings, Adverse reactionsExact identifier
rxcui: 1923433

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
b7aa1986-1c24-4733-96b3-e6d8e1d44558Cosopt (dorzolamide 20 MG / timolol 5 MG) per ML Ophthalmic SolutionSY9These highlights do not include all the information needed to use COSOPT safely and effectively. See full prescribing information for COSOPT. COSOPT ® (dorzolamide hydrochloride and timolol maleate ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 199820221202
b7aa1986-1c24-4733-96b3-e6d8e1d44558dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution [Cosopt]SBD9These highlights do not include all the information needed to use COSOPT safely and effectively. See full prescribing information for COSOPT. COSOPT ® (dorzolamide hydrochloride and timolol maleate ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 199820221202
b7aa1986-1c24-4733-96b3-e6d8e1d44558Cosopt 2 % / 0.5 % Ophthalmic SolutionSY9These highlights do not include all the information needed to use COSOPT safely and effectively. See full prescribing information for COSOPT. COSOPT ® (dorzolamide hydrochloride and timolol maleate ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 199820221202
b7aa1986-1c24-4733-96b3-e6d8e1d44558COSOPT 2 % / 0.5 % Ophthalmic SolutionPSN9These highlights do not include all the information needed to use COSOPT safely and effectively. See full prescribing information for COSOPT. COSOPT ® (dorzolamide hydrochloride and timolol maleate ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 199820221202
23bdf1c1-3134-4ad1-8e7c-bc655156bdc6COSOPT 2 % / 0.5 % Ophthalmic SolutionPSN4These highlights do not include all the information needed to use COSOPT safely and effectively. See full prescribing information for COSOPT. COSOPT ® (dorzolamide hydrochloride and timolol maleate ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 199820240417
23bdf1c1-3134-4ad1-8e7c-bc655156bdc6Cosopt 2 % / 0.5 % Ophthalmic SolutionSY4These highlights do not include all the information needed to use COSOPT safely and effectively. See full prescribing information for COSOPT. COSOPT ® (dorzolamide hydrochloride and timolol maleate ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 199820240417
23bdf1c1-3134-4ad1-8e7c-bc655156bdc6dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution [Cosopt]SBD4These highlights do not include all the information needed to use COSOPT safely and effectively. See full prescribing information for COSOPT. COSOPT ® (dorzolamide hydrochloride and timolol maleate ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 199820240417
23bdf1c1-3134-4ad1-8e7c-bc655156bdc6Cosopt (dorzolamide 20 MG / timolol 5 MG) per ML Ophthalmic SolutionSY4These highlights do not include all the information needed to use COSOPT safely and effectively. See full prescribing information for COSOPT. COSOPT ® (dorzolamide hydrochloride and timolol maleate ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 199820240417
44e3bbcd-01d4-4dba-be22-308dffecf236Cosopt (dorzolamide 20 MG / timolol 5 MG) per ML Ophthalmic SolutionSY2COSOPT ® (dorzolamide hydrochloride-timolol maleate ophthalmic solution) Sterile Ophthalmic Solution20100505
44e3bbcd-01d4-4dba-be22-308dffecf236Cosopt 2 % / 0.5 % Ophthalmic SolutionSY2COSOPT ® (dorzolamide hydrochloride-timolol maleate ophthalmic solution) Sterile Ophthalmic Solution20100505
44e3bbcd-01d4-4dba-be22-308dffecf236COSOPT 2 % / 0.5 % Ophthalmic SolutionPSN2COSOPT ® (dorzolamide hydrochloride-timolol maleate ophthalmic solution) Sterile Ophthalmic Solution20100505
44e3bbcd-01d4-4dba-be22-308dffecf236dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution [Cosopt]SBD2COSOPT ® (dorzolamide hydrochloride-timolol maleate ophthalmic solution) Sterile Ophthalmic Solution20100505